NK cells obtained from six donors were analyzed before (D0) and after (D14) culture to examine changes in NK receptor expression, and ADCC activity targeting HER2-positive cancer cells was evaluated through in vitro cell cytotoxicity assays and an in vivo xenograft mouse model. The gene discussed is ERBB2; the disease is cancer.